by Stacey Johnson | Oct 26, 2012
On the same day that I learned the (disturbing and sad) news that a friend, a woman in her early 40s, has a pacemaker, I read that a stem cell scientist in cardiovascular medicine, at the University of California, has received a grant to develop stem cells that...
by Natasha Davie | Oct 17, 2012
It has taken just six years since the release of his seminal publication on the genetic reprogramming of human somatic cells for Shinya Yamanaka to be awarded the most prestigious of all accolades: the Nobel Prize. Compare that to his co-recipient, Sir John B. Gurdon,...
by Angela C. H. McDonald | Oct 16, 2012
I periodically indulge myself in the personal lives of the Seattle Grace Hospital staff on Grey’s Anatomy. I am particularly fond of the character Dr. Addison Montgomery, world-class neo-natal surgeon. After enduring some juicy relationship drama, Addison decides to...
by Roshan Yoganathan | Oct 5, 2012
I visited London at the end of August and was exposed to the Paralympics for the first time. One of the biggest stars of the London 2012 Paralympics was Oscar Pistorius, a 200m and 400m sprinter from South Africa with double, below-knee amputations. He received...
by Stacey Johnson | Sep 26, 2012
My grandmother, at 97, is excited about stem cell research because she sees the possibilities. Regenerative medicine IS an exciting field. It’s on the cutting edge of science and fans and critics alike debate its merits regularly in the press and in blogs. Every day,...
by Paul Krzyzanowski | Sep 20, 2012
[pullquote]How will Romney’s opinion change in light of papers, which describe healthy mice being created from iPS cells?[/pullquote]As 2012 slowly creeps on we can finally see November’s Presidential Election in the United States on the horizon marking the end of a...
by Angela C. H. McDonald | Sep 11, 2012
You don’t have to follow pharmaceutical industry news to know that this summer has been a disappointing one for Alzheimer’s research. Many major media outlets covered the failure of potential Alzheimer’s drug bapineuzumab (Pfizer/Johnson & Johnson) in Phase II/III...
by Lisa Willemse | Sep 6, 2012
It seems to me that the number of media stories on stem cell clinical trials (not just preclinical work) is on the increase. Take, for example, news last month of a new clinical trial to test cord blood stem cells as a treatment for autism. This particular...
by Angela C. H. McDonald | Aug 30, 2012
If you tuned into the evening news on Monday night (at least here in Canada), you would have seen my PhD supervisor Janet Rossant, discussing a recent advancement in stem cell differentiation. Amy Wong, post-doctoral fellow in the Rossant lab, created a protocol for...
by Holly Wobma | Aug 22, 2012
With over 34 million people living with HIV, of which only the fortunate have continual access to life-saving anti-retroviral drugs, it comes as no surprise that the recent media announcement of a potential “cure” for HIV went rapidly…well…viral. The excitement...
Comments